Popular Articles

Mar 01, 2011
Pharmaceutical Executive
When dealing with the pharmaceutical marketplace, why is keeping things simple so complex?
Mar 01, 2011
Pharmaceutical Executive
With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence
Feb 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
To manage through a resource-constrained environment, it is essential to get the most out of procurement planning
Feb 01, 2011
Pharmaceutical Executive
Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story
Oct 03, 2009
Successful Product Manager's Handbook
By Pharmaceutical Executive Editors
The most imporant thing to remember when planning a global clinical trial is very basic and almost always overlooked
Oct 03, 2009
Successful Product Manager's Handbook
By Pharmaceutical Executive Editors
What you need to know in order to budget right and for less money
Aug 01, 2009
Pharmaceutical Executive
With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.
Aug 01, 2009
Pharmaceutical Executive
The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's—all at once.
Jul 07, 2009
Agency Confidential
By Pharmaceutical Executive Editors
Agency Insider Mark Chattaway infiltrates the world of online social media. His consensus: Advertising on social networks is iffy at best
Jul 01, 2009
Pharmaceutical Executive
Chris Viehbacher's first fast and furious six months at the top of Sanofi-Aventis have heads spinning...and rolling.
native1_300x100
lorem ipsum